AstraZeneca - Widening the lens beyond BRCA: Expanding our view of the DDR diagnostics pathwayAmgen - Targeting KRAS: the expanding role of precision medicine in NSCLCBiocartis - Precision Diagnostics Sharpening Treatment Decisions in OncologyAstraZeneca - FOCUS: optimising molecular testing practices in lung cancerNanoString - From Tissue to Answer: Advancements in Spatial BiologyThermo Fisher Scientific - Revolutionizing precision oncology with 1 day next generation sequencingJazz Pharmaceuticals - The enigma of high-risk AMLBristol Myers Squibb - The Next Frontier: Digital Evolution of Biomarkers in Immuno-oncologyAstraZeneca - Unlocking the potential of lung biomarkers to predict and monitor response to IOBayer - NTRK Gene Fusions - The Path to TravelNovartis - New biomarker pradigms in advanced/metastatic breast cancer - looking towards PIK3CA and beyond
AstraZeneca - FOCUS: optimising molecular testing practices in lung cancerBayer - NTRK Gene Fusions - The Path to TravelBristol Myers Squibb - The Next Frontier: Digital Evolution of Biomarkers in Immuno-oncologyJazz PharmaceuticalsThermo Fisher Scientific - Revolutionizing precision oncology with 1 day next generation sequencingAstraZeneca - Unlocking the potential of lung biomarkers to predict and monitor response to IOBiocartis - Precision Diagnostics Sharpening Treatment Decisions in OncologyAmgen - Targeting KRAS: the expanding role of precision medicine in NSCLCNovartis - New biomarker paradigms in advanced/metastatic breast cancer - looking towards PIK3CA and beyondAstraZeneca - Widening the lens beyond BRCA: Expanding our view of the DDR diagnostics pathwayNanoString - From Tissue to Answer: Advancements in Spatial Biology